{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:16:55Z","timestamp":1784809015302,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lfs.2020.118250","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T01:30:13Z","timestamp":1597109413000},"page":"118250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Polymyxin B prevents the development of adjuvant arthritis via modulation of TLR\/Cox-2 signaling pathway"],"prefix":"10.1016","volume":"259","author":[{"given":"Mennatallah A.","family":"Gowayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"El Achy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher A.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A.","family":"El-Tahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2020.118250_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11926-009-0051-z","article-title":"The role of toll-like receptors in rheumatoid arthritis","volume":"11","author":"Huang","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"issue":"9","key":"10.1016\/j.lfs.2020.118250_bb0010","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.22848","article-title":"Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis","volume":"56","author":"Abdollahi-Roodsaz","year":"2007","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"10.1016\/j.lfs.2020.118250_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2529","article-title":"Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis","volume":"10","author":"Tada","year":"2008","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"10.1016\/j.lfs.2020.118250_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/art.10848","article-title":"Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling","volume":"48","author":"Kyburz","year":"2003","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.177.1.422","article-title":"Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function","volume":"177","author":"Pecora","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118250_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.lfs.2020.118250_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1","article-title":"Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides","volume":"43","author":"Ineke","year":"2000","journal-title":"Arthritis & Rheumatism"},{"issue":"6","key":"10.1016\/j.lfs.2020.118250_bb0040","first-page":"656","article-title":"Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs","volume":"24","author":"Moen","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118250_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jbspin.2010.04.015","article-title":"Rheumatoid arthritis and periodontal disease","volume":"77","author":"Berthelot","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.lfs.2020.118250_bb0050","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/art.34539","article-title":"Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis","volume":"64","author":"Scher","year":"2012","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1016\/j.lfs.2020.118250_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2477","article-title":"TH-17 cells in rheumatoid arthritis","volume":"10","author":"Shahrara","year":"2008","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.lfs.2020.118250_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/132732","article-title":"Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis","volume":"2008","author":"Kowalski","year":"2008","journal-title":"Mediat. Inflamm."},{"issue":"12","key":"10.1016\/j.lfs.2020.118250_bb0065","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1002\/art.24127","article-title":"Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4\u2013mediated interleukin-17 production","volume":"58","author":"Abdollahi-Roodsaz","year":"2008","journal-title":"Arthritis & Rheumatism"},{"issue":"14","key":"10.1016\/j.lfs.2020.118250_bb0070","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1096\/fj.01-0432com","article-title":"Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways","volume":"15","author":"Hwang","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2020.118250_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejphar.2014.05.045","article-title":"Anti-arthritic activity of N\u2032-[(2, 4-dihydroxyphenyl) methylidene]-2-(3, 4-dimethyl-5, 5-dioxidopyrazolo [4, 3-c][1,2] benzothiazin-1 (4H)-yl) acetohydrazide","volume":"738","author":"Shabbir","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118250_bb0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cas.12901","article-title":"Inflammation in gastric cancer: interplay of the COX-2\/prostaglandin E2 and Toll-like receptor\/MyD88 pathways","volume":"107","author":"Echizen","year":"2016","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.lfs.2020.118250_bb0085","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0019-2791(76)90181-6","article-title":"Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides","volume":"13","author":"Morrison","year":"1976","journal-title":"Immunochemistry"},{"issue":"6","key":"10.1016\/j.lfs.2020.118250_bb0090","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.lfs.2020.118250_bb0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pharmthera.2017.07.012","article-title":"Polymyxins for CNS infections: pharmacology and neurotoxicity","volume":"181","author":"Velkov","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"23","key":"10.1016\/j.lfs.2020.118250_bb0100","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"Jama"},{"issue":"38","key":"10.1016\/j.lfs.2020.118250_bb0105","doi-asserted-by":"crossref","first-page":"35489","DOI":"10.1074\/jbc.M201366200","article-title":"Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers","volume":"277","author":"Flo","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2020.118250_bb0110","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1128\/JCM.01106-10","article-title":"In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae","volume":"48","author":"Elemam","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118250_bb0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/AAC.48.3.753-757.2004","article-title":"In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii","volume":"48","author":"Yoon","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.lfs.2020.118250_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1517\/14740338.2015.1088520","article-title":"The safety of polymyxin antibiotics","volume":"14","author":"Kelesidis","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01337-16","article-title":"Dosing and pharmacokinetics of polymyxin B in patients with renal insufficiency","volume":"61","author":"Thamlikitkul","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.lfs.2020.118250_bb0135","first-page":"377","article-title":"Effects of purified micronized flavonoid fraction (Detralex\u00ae) on prophylactic treatment of adjuvant arthritis with methotrexate in rats","volume":"10","author":"Rovensky","year":"2008","journal-title":"Israel Medical Association journal"},{"issue":"9","key":"10.1016\/j.lfs.2020.118250_bb0140","first-page":"1693","article-title":"Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis","volume":"31","author":"Morgan","year":"2004","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/49.1.193","article-title":"Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock","volume":"49","author":"Giacometti","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.lfs.2020.118250_bb0150","first-page":"377","article-title":"Animal models of rheumatoid arthritis","volume":"1","author":"Bendele","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12917-017-0982-y","article-title":"Refinement of intraperitoneal injection of sodium pentobarbital for euthanasia in laboratory rats (Rattus norvegicus)","volume":"13","author":"Zatroch","year":"2016","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.lfs.2020.118250_bb0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diabet.2009.06.009","article-title":"Activities of cyclooxygenases, and levels of prostaglandins E2 and F2\u03b1, in fetopathy associated with experimental diabetic gestation","volume":"36","author":"Al-Matubsi","year":"2010","journal-title":"Diabetes Metab."},{"issue":"9","key":"10.1016\/j.lfs.2020.118250_bb0170","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/JCM.00268-17","article-title":"Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-positive Enterobacteriaceae: comparison of Sensititre, MicroScan, Vitek 2, and Etest with broth microdilution","volume":"55","author":"Chew","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118250_bb0175","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1128\/AAC.02927-15","article-title":"Colistin and polymyxin B dosage regimens against Acinetobacter baumannii: differences in activity and the emergence of resistance","volume":"60","author":"Cheah","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2020.118250_bb0180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejphar.2015.07.038","article-title":"Effect of galantamine on adjuvant-induced arthritis in rats","volume":"764","author":"Gowayed","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118250_bb0185","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate","volume":"65","author":"Tian","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"2","key":"10.1016\/j.lfs.2020.118250_bb0190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1473-3099(14)70850-3","article-title":"Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus","volume":"15","author":"Nation","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0200","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/jvp.12445","article-title":"Effects of polymyxin-B on TNF-\u03b1 production in equine whole blood stimulated with three different bacterial toxins","volume":"41","author":"Bauquier","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2478\/jvetres-2018-0011","article-title":"Effects of polymyxin B on clinical signs, serum TNF-\u03b1, haptoglobin and plasma lactate concentrations in experimental endotoxaemia in sheep","volume":"62","author":"Hajimohammadi","year":"2018","journal-title":"Journal of Veterinary Research"},{"issue":"6","key":"10.1016\/j.lfs.2020.118250_bb0210","first-page":"1095","article-title":"High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis","volume":"31","author":"Dessein","year":"2004","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.aller.2013.11.003","article-title":"Inflammatory markers in patients with rheumatoid arthritis","volume":"43","author":"Shrivastava","year":"2015","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.lfs.2020.118250_bb0220","first-page":"368","article-title":"Function of nuclear factor kappa B (NF-kB) in human diseases-a review","volume":"2","author":"Serasanambati","year":"2016","journal-title":"South Ind. J. Biol. Sci"},{"issue":"23","key":"10.1016\/j.lfs.2020.118250_bb0225","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2174\/1381612043383584","article-title":"The NF-kB pathway as a potential target for autoimmune disease therapy","volume":"10","author":"Bacher","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.lfs.2020.118250_bb0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.18388\/abp.2008_3023","article-title":"The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment","volume":"55","author":"Kury\u0142owicz","year":"2008","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.lfs.2020.118250_bb0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2014.02.041","article-title":"Lipopolysaccharide differentially modulates expression of cytokines and cyclooxygenases in dorsal root ganglion cells via Toll-like receptor-4 dependent pathways","volume":"267","author":"Tse","year":"2014","journal-title":"Neuroscience"},{"issue":"25","key":"10.1016\/j.lfs.2020.118250_bb0240","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1073\/pnas.96.25.14459","article-title":"Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages","volume":"96","author":"Underhill","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2020.118250_bb0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-3083.2005.01647.x","article-title":"Reactivation of antigen-induced arthritis in mice by oral administration of lipopolysaccharide","volume":"62","author":"Yoshino","year":"2005","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2020.118250_bb0250","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/sj.bjp.0703166","article-title":"The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice","volume":"129","author":"Yoshino","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2020.118250_bb0255","first-page":"760","article-title":"Effects of methotrexate on the expression of Toll like receptor (TLR) 2 and TLR4 in human peripheral blood CD14+ mononuclear cells from patients with psoriasis vulgaris, Chinese","volume":"42","author":"Quan","year":"2009","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118250_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-7075-11-17","article-title":"Glutamine attenuates the inhibitory effect of methotrexate on TLR signaling during intestinal chemotherapy-induced mucositis in a rat","volume":"11","author":"Sukhotnik","year":"2014","journal-title":"Nutrition & Metabolism"},{"issue":"3","key":"10.1016\/j.lfs.2020.118250_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/jaut.2000.0496","article-title":"From reactive arthritis to rheumatoid arthritis","volume":"16","author":"Toivanen","year":"2001","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.lfs.2020.118250_bb0270","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/1529-0131(200010)43:10<2160::AID-ANR3>3.0.CO;2-T","article-title":"Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines","volume":"43","author":"Schrijver","year":"2000","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2020.118250_bb0275","first-page":"ii90","article-title":"Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways","volume":"63","author":"Ospelt","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"42","key":"10.1016\/j.lfs.2020.118250_bb0285","doi-asserted-by":"crossref","first-page":"32378","DOI":"10.1074\/jbc.M110.136895","article-title":"Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors","volume":"285","author":"Greenfield","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2020.118250_bb0290","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/humrep\/der234","article-title":"Toll-like receptors (TLR) 2 and 4 on human sperm recognize bacterial endotoxins and mediate apoptosis","volume":"26","author":"Fujita","year":"2011","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.lfs.2020.118250_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023539","article-title":"Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice","volume":"6","author":"Pierer","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2020.118250_bb0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","article-title":"TLR2 and TLR4 in autoimmune diseases: a comprehensive review","volume":"47","author":"Liu","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"S3","key":"10.1016\/j.lfs.2020.118250_bb0305","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Research & Therapy"},{"issue":"2","key":"10.1016\/j.lfs.2020.118250_bb0310","first-page":"118","article-title":"Inhibition of pro-inflammatory mediators and cytokines by Chlorella vulgaris extracts","volume":"8","author":"Sibi","year":"2016","journal-title":"Pharm. Res."},{"issue":"19","key":"10.1016\/j.lfs.2020.118250_bb0315","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1152\/physiolgenomics.00076.2013","article-title":"Cell cycle arrest in a model of colistin nephrotoxicity","volume":"45","author":"Eadon","year":"2013","journal-title":"Physiol. Genomics"},{"issue":"7","key":"10.1016\/j.lfs.2020.118250_bb0320","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.00070-14","article-title":"Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways","volume":"58","author":"Dai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.lfs.2020.118250_bb0325","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.02587-12","article-title":"Polymyxin B induces apoptosis in kidney proximal tubular cells","volume":"57","author":"Azad","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.lfs.2020.118250_bb0330","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0192-0561(93)90011-M","article-title":"Kidney dysfunction in the arthritic rat","volume":"15","author":"Dijoseph","year":"1993","journal-title":"Int. J. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2020.118250_bb0335","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00204-006-0094-0","article-title":"Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis","volume":"80","author":"Budancamanak","year":"2006","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118250_bb0340","first-page":"597","article-title":"Comparison of the therapeutic effects of thymoquinone and methotrexate on renal injury in pristane induced arthritis in rats","volume":"25","author":"Faisal","year":"2015","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"3","key":"10.1016\/j.lfs.2020.118250_bb0345","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02319-16","article-title":"Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B?","volume":"61","author":"Zavascki","year":"2017","journal-title":"Antimicrob. Agents Chemother."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2026.124400","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000}},{"DOI":"10.1016\/j.lfs.2026.124400","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052031002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052031002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T10:20:41Z","timestamp":1717237241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052031002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"alternative-id":["S002432052031002X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118250","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymyxin B prevents the development of adjuvant arthritis via modulation of TLR\/Cox-2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118250"}}